NEWSpublisher 2007 :: AngloChinese Investments
SEARCH COMPANY
name:
trunover in millions USD:
from:    to: 
R & D turnover in millions USD:
from:     to: 
NET profit:
from:    to: 
employees:
from:    to: 
COMPANIES
APPROVALS
ACTIVITIES ENGAGED IN
R & D
CLINICAL TRIALS
NON CLINICAL & PRECLINICAL
CHEMISTRY-CONTRACT MANUFACTURE
TEST
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY DETAILS » Anhui Anke Biotechnology (group) Co., LTD. back to previous page show list

Anhui Anke Biotechnology (group) Co., LTD.

address: 669 Changjiang Road, West, Hefei, Anhui, China
Zip Code: 230088
contact: Anke Building
International Trade Dept.
tel: 0086 - 551 - 5319890
fax: 0086 - 551 - 5319895
e-mail: ankebio@mail.hf.ah.cn

China Domestic Market Dept.
tel: 0086 - 551 – 5318811

Research &am

trunover in millions USD: 0
R & D turnover in millions USD: 0
NET profit: 0
year of financial results:
employees: 0

active in China: YES

SFDA approved: NO

Approvals:
GLP: NO
GMP: YES
AAALAC: NO
SEPA: NO

Activities engaged in:
Manufacture: NO
Active Pharmaceutical: NO
R&D: NO
Ingredients: NO
Western Generics: NO
TCM: NO

R & D:
Discovery: YES
Work Up (pilot to production): YES
Analysis: YES
Quality Control: YES
Stability: NO
Batch Release: NO

Clinical trials:
Run/Manage: NO
Data management: NO
Support Labs: NO

Non clinical & preclinical:
Animal Testing: GLP: NO
New materials Safety Assessment: NO
Pharmaceuticals: NO
Agrochemicals: NO
Industrial & Other Chemicals: NO
Non GLP - Discovery ADME: NO

Chemistry-contract manufacture:
Generics: NO
API: NO
Licensed Drugs: NO

test:
R&D: NO
 
Overview
 
Anhui Anke Biotechnology (Group) Co., Ltd., special and leading in developing, manufacturing and marketing pharmaceuticals and health-care products, have developed quickly and made remarkable success in the field of bio- technology. 

The parent company is located in Hefei New and High Technology Development Area.  As based on high-efficient Research & Development Center, AnkeBio always keep up with international development and have been undertaken with 10 subjects such as "National 863 Projects", National scientific and technological project, National key Torch Program and Scientific and Technological Projects, key scientific and technological specialties of Anhui province and Natural Fund Project and etc. and have developed nearly 10 National Novel Drugs in recent years. 

The company’s dominant products Recombinant Human Growth Hormone (Ansomone®), Series of Recombinant Human Interferon a2b (Anterferon®), MAR Kit for Anti-sperm Antibody and etc.are all developed independently. These products have more and more significant therapeutically effect on clinical testing and application of many kinds of intractable disease such as chronic hepatitis B, tumor, leukemia, nutritional support burned wound and immunopurification sterility and etc.
Its subsidiary companies like Anhui Anke Yuliangqing Pharmaceutical Co., Ltd., Anhui Anke Hengyi Pharmaceutical Co., Ltd. and Anhui Anke Xinxin Pharmaceutical Co., Ltd have been established from recombination of Anqing Yuliangqing Pharmaceutical Co., Ltd.,Tongling NO.1 Pharmaceutical Company dominated by Anke biotechnology Co.,Ltd. since year 2000.The products are extended from biomedical products into modern Chinese herb medicines and synthetic medicines.

The sales networks of their products have covered more than 30 provinces in China. More than 40 Regional Offices of AnkeBio have built up in the whole China and the international Co-operation has developed quickly.   

 
 Highlights:
AnkeBio is equipped with: 
--- The first-class manufacturing facilities and up-to-date instruments and apparatus conforming 
GMP guidelines approved by SFDA. 
--- The strong scientific background. 
--- The advanced manufacturing techniques. 
--- The stringent Quality Controls and Quality Assurance to perform bothe the analytical research 
and quality control tasks.
 
R&D
The mission of AnkeBio is discovering, developing, manufacturing and marketing health-care products with Higher Quality as well as Best Services to improving life quality of human.
 
AnkeBio devotes itself to improve life quality of human by discovering, developing, manufacturing and marketing High-Tech health-care products. R&D ability is one of the most valuable assets of Ankebio. To ensure continuous scientific achievements, Ankebio established a well-running and high-efficient Research & Development Center when Corporation was founded; all of the present marketed products were developed by Ankebio R&D Center independently.    
 
NEW PRODUCTS IN RESEARCH:
--- Recombinant Drugs
   --- Immunological & Diagnosis Products
   --- Traditional Chinese Medicines
   --- Pharmaceutical Formulation
   --- Chemical Medicine
 
 
 
 
 
 
 

 

 


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.